Page last updated: 2024-08-26

5-iodotubercidin and Leucocythaemia

5-iodotubercidin has been researched along with Leucocythaemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Awar, R; Arrowsmith, CH; Bolshan, Y; Brown, PJ; Fedorov, O; Knapp, S; Li, F; Nguyen, KT; Schapira, M; Smil, D; Tempel, W; Vedadi, M; Yu, W1
Canaani, E; Croce, CM; Nakamura, T; Nakanishi, H1

Other Studies

2 other study(ies) available for 5-iodotubercidin and Leucocythaemia

ArticleYear
Bromo-deaza-SAH: a potent and selective DOT1L inhibitor.
    Bioorganic & medicinal chemistry, 2013, Apr-01, Volume: 21, Issue:7

    Topics: Crystallography, X-Ray; Halogenation; Histone-Lysine N-Methyltransferase; Humans; Leukemia; Methyltransferases; Models, Molecular; S-Adenosylhomocysteine

2013
ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Sep-04, Volume: 104, Issue:36

    Topics: Acute Disease; Apoptosis; Cell Line, Tumor; Chromosomes, Human, Pair 4; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Genome, Human; Histone-Lysine N-Methyltransferase; Humans; Leukemia; Myeloid-Lymphoid Leukemia Protein; Oncogene Proteins, Fusion; Phosphorylation; Protein Binding; Protein Kinase Inhibitors; Receptor, EphA7; Transcription, Genetic; Tubercidin

2007